Navigation Links
Orexigen Therapeutics to Present at the Bank of America Merrill Lynch Global Healthcare Conference
Date:9/6/2013

SAN DIEGO, Sept. 6, 2013 /PRNewswire/ -- Orexigen® Therapeutics, Inc. (Nasdaq: OREX) today announced that management will present a company overview at the Bank of America Merrill Lynch Global Healthcare Conference in London. The presentation is scheduled for Thursday, September 12th at 9:30 a.m. London Time. To listen to the live webcast or a replay of the presentation, please visit the Investor Relations section of the Company's Web site at www.orexigen.com. A replay will be available for 14 days after the event.

About Orexigen® Therapeutics
Orexigen Therapeutics, Inc. is a biopharmaceutical company focused on the treatment of obesity. The Company's lead product candidate is Contrave®, which has completed Phase 3 clinical trials and for which a New Drug Application has been submitted and reviewed by the FDA. The Company has also reached agreement with the FDA on a Special Protocol Assessment (SPA) for the Light Study, the Contrave cardiovascular outcomes trial. The Company's other product candidate, Empatic™, has completed Phase 2 clinical trials. Further information about the Company can be found at www.orexigen.com

 

Orexigen Contact:

Media Contact:  McDavid Stilwell

Denise PowellVP, Corporate Communications and Business Development

BrewLife(858) 875-8629

(510) 703-9491


'/>"/>
SOURCE Orexigen Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Orexigen Therapeutics Announces European Filing Strategy and Reports Business and Financial Results for the Second Quarter Ended June 30, 2013
2. Orexigen Therapeutics to Host Second Quarter 2013 Financial Results Conference Call and Webcast
3. Orexigen Therapeutics Announces Upcoming Clinical Data Presentations at American Diabetes Association Annual Scientific Meeting
4. Orexigen Therapeutics to Present at the Jefferies 2013 Global Healthcare Conference
5. Orexigen Therapeutics to Present at the UBS Global Healthcare Conference
6. Orexigen Therapeutics Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2012
7. Orexigen Therapeutics to Host Full Year and Fourth Quarter 2012 Financial Results Conference Call and Webcast
8. Orexigen Therapeutics Announces Webcast of Upcoming Presentation at the Cowen & Co. Annual Health Care Conference
9. Orexigen Therapeutics to Present at Upcoming Investor Conferences
10. Orexigen Therapeutics To Host Analyst Day Event on December 18, 2012
11. Orexigen Therapeutics Reports Financial Results for the Third Quarter Ended September 30, 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... CORONA, Calif. and VIENNA, Va. ... an innovative in-home care provider that operates in ... with BeClose, a leading provider of remote caregiving technology. Alta ... new and existing client receiving homecare services. ... believe this technology is the key to providing the ...
(Date:11/21/2014)... Nov. 21, 2014  Heated dialogue in recent months ... from cancer treatments to Gilead,s new hepatitis C drug ... the world questioning what it means to put a ... And while drug pricing is one of ... from both a general business and ethical standpoint – ...
(Date:11/21/2014)... and MELVILLE, N.Y. , Nov. ... CAH ), one of the world,s largest health care ... HSIC ), the world,s largest provider of health care ... medical practitioners, today announced that the companies have entered ... the most comprehensive service and product offerings to office-based ...
Breaking Medicine Technology:Alta Home Care, Inc. and BeClose Partner to Enable Seniors to Remain in Their Homes Safely and Securely 2"The Price of Global Health" Tackles Worldwide Drug-Pricing Debate 2"The Price of Global Health" Tackles Worldwide Drug-Pricing Debate 3"The Price of Global Health" Tackles Worldwide Drug-Pricing Debate 4"The Price of Global Health" Tackles Worldwide Drug-Pricing Debate 5Cardinal Health And Henry Schein Enter Into Long-Term Strategic Agreement To Serve Physician Offices 2Cardinal Health And Henry Schein Enter Into Long-Term Strategic Agreement To Serve Physician Offices 3Cardinal Health And Henry Schein Enter Into Long-Term Strategic Agreement To Serve Physician Offices 4Cardinal Health And Henry Schein Enter Into Long-Term Strategic Agreement To Serve Physician Offices 5
... Biogen Idec (NASDAQ: BIIB),and Elan Corporation, plc (NYSE: ... Prescribing Program(TM) and TYGRIS safety study,confirm the safety ... presented at the 59th annual meeting,of the American ... data that showed that TYSABRI has a sustained ...
... WIRE)--May 3, 2007 - Insmed Inc.,(Nasdaq:INSM) today announced ... the company's drug, IPLEX(TM), in,patients with myotonic muscular ... being conducted at,the University of Rochester School of ... with doses of IPLEX up to 1,mg/kg/day in ...
Cached Medicine Technology:Data Presented at the American Academy of Neurology's Annual,Meeting Provide Update on Utilization and Safety of Tysabri in,Patients with Multiple Sclerosis 2Data Presented at the American Academy of Neurology's Annual,Meeting Provide Update on Utilization and Safety of Tysabri in,Patients with Multiple Sclerosis 3Data Presented at the American Academy of Neurology's Annual,Meeting Provide Update on Utilization and Safety of Tysabri in,Patients with Multiple Sclerosis 4Data Presented at the American Academy of Neurology's Annual,Meeting Provide Update on Utilization and Safety of Tysabri in,Patients with Multiple Sclerosis 5Data Presented at the American Academy of Neurology's Annual,Meeting Provide Update on Utilization and Safety of Tysabri in,Patients with Multiple Sclerosis 6Insmed Announces Promising Results From IPLEX Phase II Myotonic,Muscular Dystrophy Clinical Study 2Insmed Announces Promising Results From IPLEX Phase II Myotonic,Muscular Dystrophy Clinical Study 3Insmed Announces Promising Results From IPLEX Phase II Myotonic,Muscular Dystrophy Clinical Study 4
(Date:11/21/2014)... November 21, 2014 The Ohio Children’s ... the Ohio Chapter, American Academy of Pediatrics (Ohio AAP, ... sleep education to parents and caregivers throughout Ohio. The ... June 30, 2015, provides $75,000 to continue the campaign ... Children’s Trust Fund is excited to continue partnering with ...
(Date:11/21/2014)... 21, 2014 Midway through the research ... Inc.’s (AIS) annual Directory of Health Plans, preliminary data ... Directory of Health Plans is a comprehensive resource with ... in the U.S. The 2015 edition will ... AIS’s Directory and Databases Division, the company’s exclusive in-house ...
(Date:11/21/2014)... November 21, 2014 CDT PLUS! ... dental practice. It includes everything needed to process dental ... Coding with CDT , CDT 2015 codes are mandatory ... 1, 2014 - December 31, 2014. Dental professionals must ... services on dental claims. There are significant changes in ...
(Date:11/21/2014)... 21, 2014 RankingBySEO has announced an ... online reputation of lawyers, and the company has named ... the service for lawyers since it receives queries from ... in big numbers. So far, the company has successfully ... firms in different parts of the world, and now, ...
(Date:11/21/2014)... HealthDay Reporter THURSDAY, Nov. ... tasks may help preserve thinking skills and memory as ... researchers compared IQ scores obtained around age 11 from ... reasoning scores around age 70. The scientists found that ... sharper thinking even years after retirement. Researchers ...
Breaking Medicine News(10 mins):Health News:Ohio AAP and Ohio Children’s Trust Fund Continue Partnership for Safe Sleep Education Campaign 2Health News:Ohio AAP and Ohio Children’s Trust Fund Continue Partnership for Safe Sleep Education Campaign 3Health News:Data from Atlantic Information Services’s Forthcoming Directory Shows Volatility in U.S. Health Care Market 2Health News:PMIC Announces CDT PLUS! 2015, the Ultimate Coding Reference for Dentists and Oral Surgeons 2Health News:RankingBySEO Announces Lawyer Reputation Management Service 2Health News:Could Your Job Help Preserve Your Aging Brain? 2Health News:Could Your Job Help Preserve Your Aging Brain? 3
... chicken eggs that can be used to produce drugs like those ... at Edinburgh, Scotland have claimed to create a flock ... to create life saving drugs. ,These drugs could ... National Health Service incurs, according to them. , For ...
... gene therapy delivered in lipid-based nanoparticles drastically reduces ... lung cancer tumors in mice, researchers at The ... //and the University of Texas Southwestern Medical Center ... Research. ,Two tumor-suppressing genes given intravenously reduced ...
... including Alzheimer’s disease, is one of the most devastating ... individuals in the U.S. and 24 million worldwide, dementia ... to function independently – making it one of people’s ... confusional state, a common and serious complication in older ...
... areas—including armored vests and other protective gear, streamlined ... medical approaches—have combined to produce significant improvement// in ... Iraq and Afghanistan, according to a Special Editorial ... Craniofacial Surgery. ,For soldiers injured in combat ...
... specialist trainee doctors in England views their future job ... of changes in training and healthcare delivery, //reveals a ... of Postgraduate Medical Journal. ,While the government ... long term conditions, away from hospitals into the community, ...
... of another gene responsible for late-onset Alzheimer’s disease. This ... in around 90 percent of patients) and develops after ... University of Toronto, and Columbia University have discovered the ... ,The reasearchers spent five years locating ...
Cached Medicine News:Health News:No Pills Just Omelets 2Health News:Dual Gene Therapy Suppresses Lung Cancer in Preclinical Test 2Health News:Relationship Between Delirium and Dementia 2Health News:Relationship Between Delirium and Dementia 3Health News:Relationship Between Delirium and Dementia 4Health News:Advances Have Cut Combat Deaths in Iraq and Afghanistan 2Health News:One in Four Specialist Trainee Doctors 'Very Worried' About Future Job Prospects 2Health News:New Gene to Help in Understanding Alzheimer’s Diseas 2
... flow cytometer for all applications in Cytomics ... absolute counting. The CyFlow ML allows to ... signals in combination with up to 13 ... can perform in a wide variety of ...
This unique system combines the analytical power of a research cytometer into a compact, truly walk away, clinical analyzer ergonomically designed to expedite sample throughput....
The Mini Vidas is a compact version of the Vidas system with a built-in computer, keyboard and printer. Two independent sections each accept six tests and can process up to 12 samples simultaneously....
AIA - Nex.IA immunoassay analyzer state of the art automation and flexibility for high throughput immunoassay testing...
Medicine Products: